Literature DB >> 18550659

Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms.

Vira Bitko1, Alla Musiyenko, Mark A Bayfield, Richard J Maraia, Sailen Barik.   

Abstract

The La antigen (SS-B) associates with a wide variety of cellular and viral RNAs to affect gene expression in multiple systems. We show that La is the major cellular protein found to be associated with the abundant 44-nucleotide viral leader RNA (leRNA) early after infection with respiratory syncytial virus (RSV), a nonsegmented negative-strand RNA virus. Consistent with this, La redistributes from the nucleus to the cytoplasm in RSV-infected cells. Upon RNA interference knockdown of La, leRNA is redirected to associate with the RNA-binding protein RIG-I, a known activator of interferon (IFN) gene expression, and this is accompanied by the early induction of IFN mRNA. These results suggest that La shields leRNA from RIG-I, abrogating the early viral activation of type I IFN. We mapped the leRNA binding function to RNA recognition motif 1 of La and showed that while wild-type La greatly enhanced RSV growth, a La mutant defective in RSV leRNA binding also did not support RSV growth. Comparative studies of RSV and Sendai virus and the use of IFN-negative Vero cells indicated that La supports the growth of nonsegmented negative-strand RNA viruses by both IFN suppression and a potentially novel IFN-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550659      PMCID: PMC2519562          DOI: 10.1128/JVI.02762-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Crystal structure of the rabies virus nucleoprotein-RNA complex.

Authors:  Aurélie A V Albertini; Amy K Wernimont; Tadeusz Muziol; Raimond B G Ravelli; Cedric R Clapier; Guy Schoehn; Winfried Weissenhorn; Rob W H Ruigrok
Journal:  Science       Date:  2006-06-15       Impact factor: 47.728

2.  Separate RNA-binding surfaces on the multifunctional La protein mediate distinguishable activities in tRNA maturation.

Authors:  Ying Huang; Mark A Bayfield; Robert V Intine; Richard J Maraia
Journal:  Nat Struct Mol Biol       Date:  2006-06-25       Impact factor: 15.369

Review 3.  A terminal affair: 3'-end recognition by the human La protein.

Authors:  Stephen Curry; Maria R Conte
Journal:  Trends Biochem Sci       Date:  2006-05-06       Impact factor: 13.807

4.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

Review 5.  RNA regulons: coordination of post-transcriptional events.

Authors:  Jack D Keene
Journal:  Nat Rev Genet       Date:  2007-07       Impact factor: 53.242

6.  Structure of the vesicular stomatitis virus nucleoprotein-RNA complex.

Authors:  Todd J Green; Xin Zhang; Gail W Wertz; Ming Luo
Journal:  Science       Date:  2006-06-15       Impact factor: 47.728

7.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

8.  Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment.

Authors:  Tatiana Bousse; Raychel L Chambers; Ruth Ann Scroggs; Allen Portner; Toru Takimoto
Journal:  Virus Res       Date:  2006-05-03       Impact factor: 3.303

9.  Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling.

Authors:  Victor Fok; Kyle Friend; Joan A Steitz
Journal:  J Cell Biol       Date:  2006-05-08       Impact factor: 10.539

Review 10.  Viral suppression of the interferon system.

Authors:  Friedemann Weber; Otto Haller
Journal:  Biochimie       Date:  2007-01-27       Impact factor: 4.079

View more
  33 in total

1.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

2.  A comprehensive analysis of the La-motif protein superfamily.

Authors:  Cécile Bousquet-Antonelli; Jean-Marc Deragon
Journal:  RNA       Date:  2009-03-19       Impact factor: 4.942

Review 3.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

4.  Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses.

Authors:  Susan Morris; Michele S Swanson; Andrew Lieberman; Michelle Reed; Zhenyu Yue; Dennis M Lindell; Nicholas W Lukacs
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

5.  La proteins couple use of sequence-specific and non-specific binding modes to engage RNA substrates.

Authors:  Mark A Bayfield; Jyotsna Vinayak; Kyra Kerkhofs; Farnaz Mansouri-Noori
Journal:  RNA Biol       Date:  2019-03-18       Impact factor: 4.652

Review 6.  What Really Rigs Up RIG-I?

Authors:  Sailen Barik
Journal:  J Innate Immun       Date:  2016-07-21       Impact factor: 7.349

7.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

8.  Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways.

Authors:  Samer Swedan; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

9.  Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss.

Authors:  Sergei Gaidamakov; Olga A Maximova; Hyongi Chon; Nathan H Blewett; Hongsheng Wang; Amanda K Crawford; Amanda Day; Natalie Tulchin; Robert J Crouch; Herbert C Morse; Robert D Blitzer; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

10.  Respiratory syncytial virus polymerase can initiate transcription from position 3 of the leader promoter.

Authors:  Chadene Z Tremaglio; Sarah L Noton; Laure R Deflubé; Rachel Fearns
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.